Pharmacokinetic and toxicological considerations for the treatment of diabetes in patients with liver disease

By Scheen André J  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 10, Iss. 6, 2014-06 ,pp. : 839-857

Informa Healthcare

Access to resources Recommend Favorite

Use of Enoxaparin in Patients with Chronic Kidney Disease: Safety Considerations

By Brophy Donald F.   Sica Domenic A.  

Drug Safety, Vol. 30, Iss. 11, 2007-01 ,pp. : 991-994

Adis International

Access to resources Recommend Favorite

Pharmacokinetic Considerations in the Treatment of Inflammatory Bowel Disease

By Schwab M.   Klotz U.  

Clinical Pharmacokinetics, Vol. 40, Iss. 10, 2001-01 ,pp. : 723-751

Adis International

Access to resources Recommend Favorite

Pharmacoeconomic considerations in the health system management of anaemia in patients with chronic kidney disease and end stage renal disease

By Brophy Donald F   Ripley Elizabeth BD   Holdford David A  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 9, 2003-09 ,pp. : 1461-1469

Informa Healthcare

Access to resources Recommend Favorite

Treatment of Anxiety and Depression in Transplant Patients: Pharmacokinetic Considerations

By Crone C.C.  

Clinical Pharmacokinetics, Vol. 43, Iss. 6, 2004-01 ,pp. : 361-394

Adis International

Access to resources Recommend Favorite